openPR Logo
Press release

Middle East Tapentadol Market by Therapeutic Application Pain Management Neuropathic Pain, Cancer Pain

02-08-2018 03:12 PM CET | Health & Medicine

Press release from: Pharamceutical

Middle East Tapentadol Market by Therapeutic Application Pain

Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative treatment options are inadequate. Tapentadol is also indicated for neuropathic pain associated with diabetic peripheral neuropathy. It is widely used for management of acute, chronic, and cancer related pain among patients and is available legally on prescription. Nucynta ER is the first and only FDA-approved long-acting opioid analgesic designed to control both, nociceptive pain and neuropathic pain associated with diabetic peripheral neuropathy. Nucynta is available as Palexia outside the U.S. territory. Nucynta ER is contraindicated for patients suffering from significant respiratory depression, known or suspected gastrointestinal obstruction, acute or severe bronchial asthma or hypercarbia, including paralytic ileus, concurrent use of monoamine oxidase inhibitors (MAOIs), and Hypersensitivity (e.g. anaphylaxis, angioedema) to tapentadol or to any other ingredients of the product or use of MAOIs within a period of 14 days.

Request For Sample Copy@

Rising incidence of cancer and diabetic neuropathy in the Middle East is expected to fuel growth of the Middle East tapentadol market

According to data published in World Journal of Diabetes in 2016, the Middle Eastern and North African regions are estimated to have the second-highest rate of diabetes in the world, in turn, increasing prevalence of neuropathic pain. In Arab World, the prevalence of diabetes is projected to increase to 96.2% by 2035, as estimated by World Journal of Diabetes in 2016. Furthermore, the World Health Organization (WHO) estimated that in the Eastern Mediterranean region, including Middle East, recorded 555,318 new cases of cancer in 2012, which is projected to rise to 961,098 by 2030. Thus determining that the Eastern Mediterranean region is expected to have the highest relative increase of cancer cases among all regions in the world. According to Journal of Taibah University

Medical Sciences, 2016, the number of people suffering from diabetic neuropathic pain in countries of the Middle East were as follows:

The Middle East tapentadol market was valued at US$ 0.82 million in 2016 and is expected to witness a robust CAGR of 6.1% over the forecast period (2017-2025).
Absence of gold standard opioid therapy for neuropathic pain other than tapentadol is expected to fuel the Middle East tapentadol market growth

Neuropathic pain is caused by a dysfunction of or lesion to the central or peripheral nervous system and it is chronic in nature with a complex pathophysiology. NUCYNTA ER (tapentadol) is used in the treatment of neuropathic pain, if the pain is severe enough to require tapentadol daily, whereas it is also used in long-term opioid treatment for which alternative treatment options are inadequate. There is low quality evidence that the oral tramadol has any important beneficial effect on pain for people suffering from severe or moderate neuropathic pain, whereas the main indication of tapentadol is to treat the diabetic neuropathic pain. This proves that other opioids such as fentanyl, oxycodone, tramadol, and oxymorphone are not as effective as tapentadol in the treatment of neuropathic pain.

Major players operating in the tapentadol market include Depomed, Inc., Janssen Pharmaceutical, Inc., Grünenthal, and Allergan Plc.

Get More Details On this Report:

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Tel: +1-206-701-6702
Visit our news Website:

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Middle East Tapentadol Market by Therapeutic Application Pain Management Neuropathic Pain, Cancer Pain here

News-ID: 937410 • Views:

More Releases from Pharamceutical

Interventional Oncology Solutions Market Ablation Radiofrequency Ablation, Cryo Ablation Therapy
Interventional Oncology Solutions Market Ablation Radiofrequency Ablation, Cryo …
Interventional oncology is a field of medical science, which includes treatment and diagnosis of cancer and other problems related to cancer using minimally invasive procedures. Interventional oncology uses various techniques such as Ultrasound, computed tomography, X-ray, and magnetic resonance imaging (MRI) to treat tumors located in various organs of the body. Interventional oncology procedures are usually used to treat metastatic or primary cancer. These procedures can be used to treat
Congestive Heart Failure Drugs Market, by Drug Type ACE Inhibitors, Angiotensin 2 Receptor Blockers
Congestive Heart Failure Drugs Market, by Drug Type ACE Inhibitors, Angiotensin …
Major driver for growth of the congestive heart failure drugs market is the robust pipeline of drugs under development. For instance, furosemide injection solution (SCP-101) sponsored by Johns Hopkins University in collaboration with Scpharmaceuticals Inc. was in phase 2 clinical trials in 2015, this injection is indicated for treatment of heart failure. Furosemide and Azosemide sponsored by Hyogo College of Medicine has completed phase 4 clinical trials in 2016, these
New improved medication with lesser side effects will drive the insomnia therapeutics market growth globally
New improved medication with lesser side effects will drive the insomnia therape …
Benzodiazepines (BZP) such as temazepam and diazepam are the commonly prescribed medication for insomnia. Though these medications are effective, prolonged use of these drugs may cause cognitive impairment, dependency and addiction. The launch of novel drugs such as Intermezzo (2014), tasimelteon (2014) have created a meteoric growth in G7 countries in the insomnia therapeutics and is expected market over the forecast period. Intermezzo (2014), are used in small doses and administered
Antiepileptic Drugs Market - Global Industry Insights,
Antiepileptic Drugs Market - Global Industry Insights,
Antiepileptic Drugs Market Regional Analysis North America and Europe are expected to witness significant growth in the market over the forecast period due to robust pipeline for epilepsy treatment and individual efforts by leading manufacturers. For instance, Pfizer, Inc. entered into partnership with Epilepsy Foundation to find solutions for generic forms of epilepsy and associated neurological disorders in 2014. Asia Pacific region is expected to show positive developments over the forecast

All 5 Releases

More Releases for East

Middle East Auto Component Market Significant Growth over Forecast Period 2020-2 …
Auto Component Market is those markets which are manufacture components or parts required in the automobile industry. Middle East Auto Components market was valued at $ 28 billion in 2019 and is expected to surpass $ 39.7+ billion by 2028. Projected growth in the market can be recognized as snowballing automobile vehicle fleet and rising manufacture and infrastructural activities across different countries of the region. Moreover, mounting demand for vehicle
Exciting East African energy projects in progress at Future Energy East Africa i …
Energy project developers and investors in East Africa are all talking about the huge impact that mini grids and off grid power projects can make as the region plays catch-up in its generation capacity. Several exciting projects will be in focus at the 20th edition of the Future Energy East Africa conference and exhibition, formerly known as EAPIC or the East African Power Industry Convention, which returns to the KICC
Studying the Middle East Yacht Market,Studying the Middle East Yacht Industry, S …
Latest industry research report on: Studying the Middle East Yacht Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Our analysts believe that the long-term outlook for the yacht market in the Middle East is positive. Demand for yachts in the Middle East has remained stable and is expected to continue being so. Yachting has emerged as a key aspect of the luxury lifestyle in the
Middle East Railway Sector Middle East Railway Sales Report
For Report Sample Contact: or +91-11-47067990 Report Table of Contents Middle East Outlook 1.1 Countries Overview 1.2 Middle East Economy 1.3 Transportation in Middle East Middle East Rail Transport Outlook 2.1 Overall Status of Rail Transport in Middle East 2.2 Trends in Railway Infrastructure Development in Middle East Saudi Arabia 3.1 Existing Railway Infrastructure 3.2 Proposed/Planned Railway Infrastructure 3.3 Regulatory Framework 3.4
Paperworld Middle East And Playworld Middle East Set To Build On Initial Success
THE TRADE EVENTS REFLECT CHANGING TRENDS IN REGIONAL MARKET Building on their successful debuts last season, Paperworld Middle East and Playworld Middle East are set to consolidate their presence in the market as significant trade exhibitions, as they get underway at the Dubai International Convention and Exhibition Centre next week from March 6th to 8th. Organiser Epoc Messe Frankfurt is upbeat about the prospects for both shows, which are co-located in order
Digital Signage Expo East & Interactive Technology East Debut to Accolades from …
Philadelphia, PA –Digital Signage Expo East (DSE East) and Interactive Technology Expo East (ITEE), the regional versions of the international Digital Signage Expo and Interactive Technology Expo, today announced that qualified attendees to the show surpassed expectations and numbered in excess of 900! (Final and more comprehensive attendance statistics are pending)." The new regional event delivered on its promise to attract a more regional audience, of end-users, brand and advertising executives